Coya Therapeutics, Inc. (COYA) Financials

COYA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 53.3 billion 4.3 billion
Dec. 31, 2025 50.0 million 6.9 million
Sept. 30, 2025 32.0 million 4.8 million
June 30, 2025 33.5 million 5.1 million

COYA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -6.2 million 2.2 billion
Dec. 31, 2025 -1.0 million 3.2 billion
Sept. 30, 2025 -1.1 million 1.1 million
June 30, 2025 -5.8 million 1.0 million

COYA Net Income

No data available :(

COYA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 50.7 billion - -
Dec. 31, 2025 46.8 million - -
Sept. 30, 2025 28.1 million - -
June 30, 2025 29.8 million - -

COYA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 16.7 million
Dec. 31, 2025 16.7 million
Sept. 30, 2025 16.7 million
June 30, 2025 16.7 million

COYA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 4.1 million 3.8 billion -
Dec. 31, 2025 3 6.7 million 3.3 million -
Sept. 30, 2025 3 2.9 million 2.6 million -
June 30, 2025 4 3.7 billion 2.9 billion -

COYA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 251147 2807
Dec. 31, 2025 4.0 million -5.2 million
Sept. 30, 2025 3.6 million 6840
June 30, 2025 163616 6840

COYA

Price: $4.25

52 week price:
3.71
7.75

Earnings Per Share: -1.15 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Market Capitalization: 106.7 million

Links: